Pralsetinib
Drug Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Pralsetinib |
| Trade Name | Gavreto |
| Synonyms | BLU667|BLU-667 |
| Drug Descriptions |
Gavreto (pralsetinib) is a small molecule inhibitor that selectively targets activated Ret, which may result in antitumor activity including inhibition of tumor growth and tumor regression (PMID: 29657135). Gavreto (pralsetinib) is FDA approved for use in patients with metastatic RET fusion-positive non-small cell lung cancer, and in adult and pediatric patients 12 years of age and older with RET fusion-positive thyroid cancer who are radioactive iodine-refractory (FDA.gov). |
| DrugClasses | RET Inhibitor 53 |
| CAS Registry Number | 2097132-94-8 |
| NCIT ID | C132295 |
Filtering
- Case insensitive filtering will display rows if any text in any cell matches the filter term
- Use simple literal full or partial string matches
- Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
- Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
- Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")
Sorting
- Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
- Click on any column header arrows to sort by that column
- Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Afatinib + Pralsetinib | Afatinib Pralsetinib | 0 | 0 |
| Cetuximab + Pralsetinib | Cetuximab Pralsetinib | 0 | 0 |
| Crizotinib + Pralsetinib | Crizotinib Pralsetinib | 0 | 0 |
| Ensartinib + Pralsetinib | Ensartinib Pralsetinib | 0 | 0 |
| JC-010a + Pralsetinib | JC-010a Pralsetinib | 0 | 0 |
| Lorlatinib + Pralsetinib | Lorlatinib Pralsetinib | 0 | 0 |
| Osimertinib + Pralsetinib | Osimertinib Pralsetinib | 0 | 0 |
| Palbociclib + Pralsetinib | Palbociclib Pralsetinib | 0 | 0 |
| Pralsetinib | Pralsetinib | 52 | 3 |
CKB BOOST